324 related articles for article (PubMed ID: 17557757)
21. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
[TBL] [Abstract][Full Text] [Related]
22. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction.
Owerbach D; Ballard AL; Draznin MB
J Clin Endocrinol Metab; 1992 Mar; 74(3):553-8. PubMed ID: 1740489
[TBL] [Abstract][Full Text] [Related]
23. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
[TBL] [Abstract][Full Text] [Related]
24. p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients.
Concolino P; Mello E; Patrosso MC; Penco S; Zuppi C; Capoluongo E
Metabolism; 2012 Apr; 61(4):519-24. PubMed ID: 22014889
[TBL] [Abstract][Full Text] [Related]
25. Structural analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency.
Lee HH; Niu DM; Lin RW; Chan P; Lin CY
J Hum Genet; 2002; 47(10):517-22. PubMed ID: 12376740
[TBL] [Abstract][Full Text] [Related]
26. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
White PC; Speiser PW
Endocr Rev; 2000 Jun; 21(3):245-91. PubMed ID: 10857554
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of 17-OH-progesterone (OHPG) for diagnosis of congenital adrenal hyperplasia (CAH).
Singh RJ
Methods Mol Biol; 2010; 603():271-7. PubMed ID: 20077078
[TBL] [Abstract][Full Text] [Related]
28. Congenital adrenal hyperplasia: phenotype and genotype.
Hughes I
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1329-40. PubMed ID: 12510987
[TBL] [Abstract][Full Text] [Related]
29. Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation.
Toraman B; Ökten A; Kalay E; Karagüzel G; Dinçer T; Açıkgöz EG; Karagüzel A
Gene; 2013 Jan; 513(1):202-8. PubMed ID: 23142378
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
[TBL] [Abstract][Full Text] [Related]
31. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module.
Lee HH
Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189
[TBL] [Abstract][Full Text] [Related]
32. Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia.
Lee HH; Chao HT; Ng HT; Choo KB
J Med Genet; 1996 May; 33(5):371-5. PubMed ID: 8733045
[TBL] [Abstract][Full Text] [Related]
33. Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements: pitfalls and molecular diagnostic solutions.
Mao R; Nelson L; Kates R; Miller CE; Donaldson DL; Tang W; Ward K
Prenat Diagn; 2002 Dec; 22(13):1171-6. PubMed ID: 12478627
[TBL] [Abstract][Full Text] [Related]
34. [Virilizing congenital adrenogenital syndrome with a de novo I172N mutation: study of a new case].
Díez López I; Rodríguez Estévez A; González Molina E; Martínez Ayucar M; Rodríguez Pérez B; Ezquieta Zubicaray B
An Pediatr (Barc); 2010 Jan; 72(1):72-8. PubMed ID: 19819201
[TBL] [Abstract][Full Text] [Related]
35. Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction.
Riepe FG; Hiort O; Grötzinger J; Sippell WG; Krone N; Holterhus PM
J Clin Endocrinol Metab; 2008 Jul; 93(7):2891-5. PubMed ID: 18445671
[TBL] [Abstract][Full Text] [Related]
36. [A new DNA diagnostic system for the detection of human CYP21 gene mutations associated with adrenal cortex hyperplasia].
Barannik AP; Koltunova AA; Ozolinia LA; Lavrova NV; Shilov IA; Guzov II; Patrushev LI
Bioorg Khim; 2010; 36(3):354-65. PubMed ID: 20644590
[TBL] [Abstract][Full Text] [Related]
37. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
[TBL] [Abstract][Full Text] [Related]
38. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees.
Day DJ; Speiser PW; Schulze E; Bettendorf M; Fitness J; Barany F; White PC
Hum Mol Genet; 1996 Dec; 5(12):2039-48. PubMed ID: 8968761
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of the CYP21A2 gene in dried blood spot samples.
Marino S; Perez Garrido N; Ramírez P; Pujana M; Dratler G; Belgorosky A; Marino R
Medicina (B Aires); 2020; 80(3):197-202. PubMed ID: 32442933
[TBL] [Abstract][Full Text] [Related]
40. Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Krone N; Riepe FG; Partsch CJ; Vorhoff W; Brämswig J; Sippell WG
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):111-7. PubMed ID: 16636976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
